Top 5 Undervalued Companies To Watch In Right Now

Top 5 Undervalued Companies To Watch In Right Now: Dollar Tree Inc.(DLTR)

Dollar Tree, Inc. operates discount variety stores in the United States and Canada. Its stores offer merchandise primarily at the fixed price of $1.00. The company operates its stores under the names of Dollar Tree, Deal$, Dollar Tree Deal$, Dollar Giant, and Dollar Bills. Its stores offer consumable merchandise, including candy and food, and health and beauty care, as well as household consumables, such as paper, plastics, household chemicals, in select stores, and frozen and refrigerated food; variety merchandise, which includes toys, durable housewares, gifts, party goods, greeting cards, softlines, and other items; and seasonal goods, such as Easter, Halloween, and Christmas merchandise. As of April 30, 2011, it operated 4,089 stores in 48 states and the District of Columbia, as well as 88 stores in Canada. The company was founded in 1986 and is based in Chesapeake, Virginia.

Advisors' Opinion:

• [By Jayson Derrick]

  Analysts at BMO Capital downgraded Dollar Tree (NASDAQ: DLTR) to Market Perform from Outperform with a price target lowered to $59 from a previous $69. Also, analysts at Jefferies maintained a Hold rating on Dollar Tree with a price target raised to $56 from a previous $51. Shares lost 0.78 percent, closing at $54.44.

• [By Brendan Byrnes]

  Brendan: Not a problem at all. What about the surprising amount of dollar-store companies that are public? You have Family Dollar (NYSE: FDO  ) , Dollar Tree (NASDAQ: DLTR  ) , Dollar General (NYSE: DG  ) . You mention, in particular, Family Dollar, which is the lowest market cap out of all of those, as doing the best, an exceptional company. Why?

source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/top-5-undervalued-companies-to-watch-in-right-now-4.html

Top 5 Industrial Disributor Stocks To Invest In 2015

Buoyed by a solid employment report for the month of April, both the S&P 500 (SNPINDEX: ^GSPC  ) and the narrower, price-weighted Dow Jones Industrial Average (DJINDICES: ^DJI  ) achieved new record highs on a 1% daily gain. It was also a day for symbolic and psychological levels, as the S&P 500 closed above 1,600 for the first time, while the Dow broke 15,000 on an intraday basis for the first time. Small-cap stocks also participated, with the Russell 2000 Index also making a new all-time high on a 1.6% increase.

With multiple new highs set and big levels broken, it's no wonder the VIX Index (VOLATILITYINDICES: ^VIX  ) , Wall Street's fear gauge, fell 5%, to close below 13. (The VIX is calculated from S&P 500 option prices and reflects investor expectations for stock market volatility over the coming 30 days.)

Investors aren't buying it
At the end of last month, I christened the current bull market a "risk-refusal rally," in which "investors -- particularly individuals -- have returned to the stock market only grudgingly and with extreme caution." One need only look at the sentiment data to see this.

Hot Beverage Companies To Invest In 2016: Nuveen Select Maturities Municipal Fund (NIM)

Nuveen Select Maturities Municipal Fund is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is managed by Nuveen Asset Management. It invests in the fixed income markets of the United States. The fund invests primarily in municipal securities rated Baa/BBB or better. It invests in securities that provide income exempt from federal income tax. The fund employs fundamental analysis with bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the S&P Intermediate Municipal Bond Index and the S&P National Municipal Bond Index. Nuveen Select Maturities Municipal Fund was formed on September 18, 1992 and is domiciled in the United States.

Advisors' Opinion:

• [By Ning Jia]

  Net interest margin (NIM): The NIM is calculated by dividing net interest income by average earning
  assets. The NIM can vary with the particular business mix and risk taken.

Top 5 Industrial Disributor Stocks To Invest In 2015: Bioanalytical Systems Inc.(BASI)

Bioanalytical Systems, Inc. provides drug discovery and development services for pharmaceutical, biotechnology, academic, and government organizations primarily in North America, the Pacific Rim, and Europe. The company operates in two segments, Contract Research Services and Research Products. The Contract Research Services segment offers various services, including product characterization, method development, and validation; bioanalytical testing to measure drug and metabolite concentrations in complex biological matrices; stability testing to establish and confirm product purity, potency, and shelf life; in vivo sampling services for the continuous monitoring of chemical changes in life; and pharmacokinetic and safety testing services, as well as provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing services. The Research Products segment offers analytical products compris ing liquid chromatographic and electrochemical instruments with associated accessories; in vivo sampling products, such as Culex family of automated in vivo sampling and dosing instruments; and Vetronics? products consisting of instruments and related software to monitor and diagnose cardiac function, and measure other vital physiological parameters in cats and dogs. The company was founded in 1974 and is headquartered in West Lafayette, Indiana.

Advisors' Opinion:

• [By Laura Brodbeck]

  Monday

  Earnings Releases Expected: Steelcase (NYSE: SCS), Bioanalytical Systems (NASDAQ: BASI) Economic Releases Expected: Italian trade balance, Greek current account, US existing home sales

  Tuesday

Top 5 Industrial Disributor Stocks To Invest In 2015: Armco Metals Holdings Inc (AMCO)

Armco Metals Holdings, Inc., formerly China Armco Metals, Inc., incorporated on April 25, 2007, is engaged in metal ore trading and distribution and scrap metal recycling. The Company�� s operations are conducted primarily in the People's Republic of China (PRC). In the Company's metal ore trading and distribution business, the Company imports, sells and distributes to the metal refinery industry in the PRC a range of metal ore which includes iron, chrome, nickel, copper and manganese ore, as well as non-ferrous metals, and coal. The Company obtains these raw materials from global suppliers primarily in Brazil, India, Indonesia, Ukraine and the United States and distributes them in the PRC. In addition, it provides sourcing and pricing services for various metals to its network of customers.

The Company�� scrap metal recycling business, it recycles scrap metal at its recycling facility and sell the recycled product to steel mills in China for use in the production of recycled steel. The Company sells processed and non-ferrous ore to end-users, such as specialty steelmakers, foundries, aluminum sheets and ingot manufacturers, copper refineries and smelters, brass and bronze ingot manufacturers, wire and cable producers, utilities and telephone networks. The Company recycles scrap metals at the Facility using both heavy equipment and manual labors. Recycling scrap metal consists of a variety of steps, including collecting, inspecting, sorting, stripping, shearing, cutting, shredding and bailing.

Advisors' Opinion:

• [By James E. Brumley]

  It's still too soon to put it in your portfolio, but Armco Metals Holdings Inc. (NYSE:AMCO) most definitely deserves a place on your watchlist. This Chinese metal stock is poised for a breakout move. It just needs the right nudge, and a little help on a certain front to let AMCO take flight.

Top 5 Industrial Disributor Stocks To Invest In 2015: Valhi Inc.(VHI)

Valhi, Inc., through its subsidiaries, operates in the chemicals, component products, and waste management businesses. Its Chemicals segment produces and markets titanium dioxide pigment, a white inorganic pigment used to impart whiteness, brightness, and opacity for applications, such as coatings, plastics and paper, inks, food, and cosmetics. It also mines ilmenite in Norway. The company?s Component Products segment manufactures mechanical and electrical cabinet locks and other locking mechanisms, including disc tumbler locks, pin tumbler locking mechanisms, and electronic locks for the postal, transportation, furniture, banking, vending, general cabinetry, and other industries. Its security products are used in various applications, including ignition systems, mailboxes, file cabinets, desk drawers, tool storage cabinets, vending and gaming machines, high security medical cabinetry, electrical circuit panels, storage compartments, gas station security, bank bags, and p arking meters. It also provides furniture components comprising precision ball bearing slides and ergonomic computer support systems for use in applications, such as file cabinets, desk drawers, computer related equipment, home appliances, tool storage cabinets, imaging equipment, and automated teller machines. In addition, this segment manufactures and distributes stainless steel exhaust components, gauges, throttle controls, hardware, and accessories primarily for performance boats. Valhi?s Waste Management segment engages in processing, treating, storing, and disposing hazardous, toxic, and low-level radioactive wastes. This segment serves chemical, aerospace, and electronics businesses, as well as governmental agencies. Valhi also offers insurance brokerage and risk management services; holds marketable securities; provides utility services; and owns and develops properties. The company was founded in 1932 and is based in Dallas, Texas. Valhi, Inc. is a subsidiary of Co ntran Corporation.

Advisors' Opinion:

• [By John Udovich]

  Dallas billionaire Harold Simmons died over the weekend with investors sending shares of some of his publically traded companies like Valhi, Inc (NYSE: VHI), Kronos Worldwide, Inc (NYSE: KRO), NL Industries, Inc (NYSE: NL) and�CompX International Inc (NYSEMKT: CIX)to higher levels as they anticipate changes���such as asset sales or spin offs. Harold Simmons was the embodiment of the American dream because he was born during the depths of the Great Depression in Golden, Texas to schoolteacher parents and he spent�his early years living without indoor plumbing or electricity. However and by recognizing�underpriced assets and through the use of massive amounts of leverage (e.g. junk bonds),�he built an empire and�ranked #40 on the 2013 Forbes 400 with a fortune estimated to be worth some $10 billion.

• [By Ben Levisohn]

  Typically, when the chairman of a company dies, its shares drop. That hasn’t been the case for Valhi (VHI), Kronos Worldwide (KRO) and NL Industries (NL), which have all advanced today after Harold Simmons passed away.

5 Best Rising Stocks To Own Right Now

5 Best Rising Stocks To Own Right Now: iShares US Home Construction ETF (ITB)

iShares Dow Jones U.S. Home Construction Index Fund (the Fund) is a non-diversified index fund. The Fund seeks investment results that correspond to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Select Home Construction Index (the Index).

The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Index measures the performance of the home construction sector of the United States equity market, and includes companies that are constructors of residential homes, including manufacturers of mobile and prefabricated homes.

Advisors' Opinion:

• [By Paul Ausick]

  The recovery may be real, but it is stalling a bit today. The iShares Dow Jones U.S. Home Construction (NYSEMKT: ITB) is down 1.3%, at $20.92 in a 52-week range of $17.67 to $26.21.

• [By Ben Levisohn]

  Susquehanna’s head of derivative strategy Trevor Mottl, however, recommends betting against the sector with options on the iShares U.S. Home Construction ETF (ITB) following Friday’s big drop in new home sales. He writes:

• [By Ryan Detrick, Senior Technical Strategist, Schaeffer's Investment Research, Inc.]

  The action in housing stocks is another concern. The iShares Dow Jones US Home Construction Index Fund (ITB) is in the midst of making a very bearish-looking head-and-shoulders peak.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/5-best-rising-stocks-to-own-right-now.html

Best European Stocks To Watch Right Now

Best European Stocks To Watch Right Now: Flamel Technologies S.A.(FLML)

Flamel Technologies S.A., a biopharmaceutical company, engages in the development and commercialization of controlled-release therapeutic products based on its proprietary polymer based technology in the United Kingdom, Ireland, the United States, France, and Europe. The company develops nanogel Medusa technology, which is intended to provide controlled release following injection of therapeutic proteins, peptides, and other molecules; a microparticle adaptation of the Medusa platform that is intended for use in the delivery of smaller proteins and peptides; and Micropump technology, a microparticle technology for oral administration of small molecule drugs with applications in controlled-release, taste-masking, and bioavailability enhancement; and Trigger-Lock technology, an adaptation based on Micropump technology, which is intended to minimize the misuse and abuse of medications subject to abuse. Its principal product based on Micropump technology is Coreg CR, which is intended for the treatment of moderate to severe heart failure and left ventricular dysfunction following myocardial infarction. The company?s products under development based upon Medusa technology include Interferon-alpha, a naturally occurring protein that the body uses for the treatment of Hepatitis C virus and as a immune response; and FT-105, an injectable insulin formulation for diabetic patients. Its products based on its Micropump technology comprise LiquiTime for the elderly and pediatric patient patients, or others who have difficulty swallowing. The company has strategic alliance with Baxter International, Inc.; GlaxoSmithKline; Merck Serono; and Pfizer Inc, as well as has a joint development agreement with Digna Biotech, S.L. Flamel Technologies S.A. was founded in 1990 and is headquartered in Venissieux, France.

Advisors' Opinion:

[By Anna Prior]

Flamel Technologies SA(FLML) said the U.S. Food and Drug Administration has approved the company’s new drug application for Vazculep, an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. American depositary shares rose 5.1% to $14.78 in premarket trading.

• [By Garrett Cook]

  Healthcare shares gained 0.81 percent in the US market on Friday. Top gainers in the sector included Shire plc (NASDAQ: SHPG), StemCells (NASDAQ: STEM), and Flamel Technologies SA (NASDAQ: FLML).

• [By Garrett Cook]

  Healthcare shares gained 0.81 percent in the US market on Friday. Top gainers in the sector included Shire plc (NASDAQ: SHPG), StemCells (NASDAQ: STEM), and Flamel Technologies SA (NASDAQ: FLML).

source from Top Stocks For 2015:http://www.topstocksblog.com/best-european-stocks-to-watch-right-now-3.html

$866M Wealth Team Joins LPL-Affiliated Firm

Northstar Wealth Partners (NSWP), an affiliate of LPL Financial (LPLA), said it recently added a team of fee-based advisors who manage more than $866 million in assets.

The addition of Tyler Potts and J. Addison McAraw, announced on the partnership’s website last week, brings Northstar’s level of assets under management to nearly $2 billion. In addition, Northstar says it will open a new office in the Old Saybrook area of Connecticut, where the newly recruited team lives and works.

“The addition of this team to the Northstar family further demonstrates the firm’s commitment to being the independent financial services firm of choice for elite advisors who call Connecticut home,” the partnership said in an online announcement.

“Northstar is honored to welcome Tyler and J as Partners to our firm,” said Robert Laraia and Brandon Marinelli, founders of West Hartford, Conn.-based Northstar, in a statement. “We share their commitment to longevity, sustainability and scale for our clients and our business as a whole.”

Top 10 Trucking Companies To Watch For 2016

Northstar currently includes 22 partners and eight staff members who serve small-business owners, senior executives, experienced professionals, retirees and families with financial planning and related advice.

Top Railroad Stocks To Buy Right Now

Top Railroad Stocks To Buy Right Now: Vimicro International Corporation(VIMC)

Vimicro International Corporation, through its subsidiaries, designs, develops, and markets mixed-signal semiconductor products and system-level solutions for the consumer electronics, communications, and surveillance markets in Mainland China, Taiwan, Japan, Korea, and Hong Kong. It provides mixed-signal multimedia processors for personal computer and embedded notebook cameras, as well as for mobile phones. The company also offers system-level solutions that include integrated semiconductors, customizable firmware and software, software development tools, reference designs, and applications support. In addition, it provides security and surveillance products comprising video capturing, compression, transmission, storage, processing, display, and video analysis products. Further, the company involves in packaging, testing, and reselling third party image sensors. It sells its multimedia processor products through direct sales force and distributors to original design manuf acturers, original equipment manufacturers, design houses, and module manufacturers, as well as its security and surveillance products to government entities, telecommunications operators, schools, banks, railway companies, supermarkets, and theaters. The company was founded in 1999 and is based in Beijing, the People?s Republic of China.

Advisors' Opinion:

• [By Lisa Levin]

  Vimicro International (NASDAQ: VIMC) shares climbed 26.91% to $11.60. The volume of Vimicro International shares traded was 741% higher than normal. Vimicro announced a $12.4 million contract win in Taiyuan City of Shanxi Province. The company's joint venture, Shanxi Zhongtianxin Science and Technology Co, secured a $65 million revolving line of credit.

• [By Lisa Levin]

  Vimicro International (NASDAQ: VIMC) shares reached a new 52-week! high of $11.70 after the company announced a $12.4 million contract win in Taiyuan City of Shanxi Province. The company's joint venture, Shanxi Zhongtianxin Science and Technology Co, secured a $65 million revolving line of credit.

• [By Paul Ausick]

  Beijing-based Vimicro International Corp. (NASDAQ: VIMC) was up about 33% after the company raised its guidance for the fourth quarter of 2013 and the first quarter of 2014. The company is a fabless designer and marketer of mixed-signal processors and other products for the consumer, communications and surveillance markets in China and Hong Kong. Shares trade at around $4.00 in a 52-week range of $1.10 to $4.64, and that high was set earlier today. About 1.4 million shares had traded hands, more than 10 times the daily average of around 100,000.

source from Top Stocks For 2015:http://www.topstocksblog.com/top-railroad-stocks-to-buy-right-now-6.html

Top 10 Casino Companies To Buy Right Now

Top 10 Casino Companies To Buy Right Now: Tropicana Entertainment Inc (TPCA)

Tropicana Entertainment Inc. (TEI) is an owner and operator of regional casino and entertainment properties located in the United States and one casino resort development located on the island of Aruba. TEI's United States properties include three casinos in Nevada, three casinos in Mississippi, and one casino in each of Indiana, Louisiana and New Jersey. Its properties offer a range of gaming options. TEI's properties include Tropicana AC in the East; Casino Aztar in Central; Tropicana Laughlin, River Palms and MontBleu in the West; Lighthouse Point, Jubilee, Belle of Baton Rouge, Horizon Vicksburg and Tropicana Aruba in the South and Other.

Tropicana AC

Tropicana Casino and Resort, Atlantic City (Tropicana AC) is situated on a 14-acre site with approximately 660 feet of ocean frontage in Atlantic City, New Jersey. In addition to gaming facilities, the property features The Quarter, a Havana-themed, Las Vegas-style, approximately 200,000 sq uare-foot indoor entertainment and retail center, hosting several restaurants, shops and an IMAX theatre. Other amenities include a 2,000-seat showroom, a full service spa and salon, a health club and indoor pool, a beach and pool bar and approximately 99,000 square feet of meeting and convention space.

Casino Aztar

Casino Aztar Evansville (Casino Aztar) is a casino hotel and entertainment complex in the state of Indiana. Over 60% of Casino Aztar's revenues come from customers within a 50-mile radius. The property's casino operations are located dockside on the three-deck City of Evansville riverboat. Located adjacent to the casino, the Company owns two distinctive hotels: the Casino Aztar Hotel, a 251-room hotel that offers guests a restaurant, conference rooms and banquet facilities; and Le Merigot Hotel, a luxurious 96-room bouti! que hotel with an upscale martini lounge. A 44,000-square-foot pavilion adjacent to the riverboat features three resta urants, an entertainment lounge, gift shop, coffee shop, pla! yers club and VIP lounge. The District at Casino Aztar includes two restaurants and the Le Merigot Hotel. Casino Aztar also includes a seven-story parking garage, as well as surface parking.

Tropicana Laughlin

Tropicana Laughlin Hotel and Casino (Tropicana Laughlin) is located on an approximately 31-acre site on Casino Drive, Laughlin. The casino at Tropicana Laughlin features a gaming floor. Non-gaming amenities include a heated outdoor swimming pool, seven restaurants, three full service bars, an entertainment lounge with live music, a lounge for high-end players, an 800-seat multi-purpose showroom and concert hall, meeting space, retail stores, an arcade and a covered parking structure. The property features 1,495 hotel rooms.

River Palms

River Palms Hotel and Casino (River Palms) is located on an approximately 35-acre site also on Casino Drive, with approximately 1,300 feet of frontage on the Colorado River. Non-gami ng amenities include 1,001 hotel rooms, 10,500 square feet of meeting and convention space, an outdoor pool, fitness center, three restaurants, three full service bars, a showroom, two entertainment lounges with live music and a covered parking structure.

MontBleu

MontBleu Casino Resort & Spa (MontBleu) is situated on approximately 21 acres in South Lake Tahoe, Nevada surrounded by the Sierra Nevada Mountains. In addition to the casino, the property offers guests a choice of three restaurants and various non-gaming amenities, including retail shops, two nightclubs, a 1,500-seat showroom, approximately 14,000 square feet of meeting and convention space, a parking garage, a full service health spa and workout area, an indoor heated lagoon style pool with whirlpool and a 120-seat wedding chapel.

Lighthouse Point

Lighthouse Point Casino (Lighthouse Point) is a 210-foot, three-deck, dockside riverboat located in Greenville, Mississippi. In addition to slot machines, the riverboat inc! ludes a d! eli and bars on each floor while the dockside facility includes a buffet, a bar and 386 onsite surface parking spaces.

Jubilee

Bayou Caddy's Jubilee Casino (Jubilee), a 240-foot dockside riverboat, is located in Greenville. In addition to the casino facilities, the property includes a bar on each floor, a deli and approximately 700 parking spaces. The property also owns and operates the Greenville Inn & Suites, a 41-room suite hotel located less than a mile away, which offers free shuttle service to and from Jubilee and Lighthouse Point.

Belle of Baton Rouge

Belle of Baton Rouge Casino & Hotel (Belle of Baton Rouge) is a dockside riverboat situated on approximately 23 acres on the Mississippi River in the downtown historic district of Baton Rouge, across from the River Center, a 70,000-square-foot convention center. The three-deck, dockside riverboat casino is one of two casino facilities in the Baton Rouge market. Bato n Rouge is located 75 miles north of New Orleans. Non-gaming amenities include 300 hotel rooms, 25,000 square feet of meeting and convention space, an outdoor pool, a fitness center, two restaurants, a deli, and an entertainment venue inside a 50,000-square-foot glass atrium that also encloses a tropical lobby.

Horizon Vicksburg

Horizon Vicksburg Casino (Horizon Vicksburg) is a dockside riverboat situated on approximately six acres in downtown Vicksburg, Mississippi. The property features a 297-foot multi-level, antebellum style, dockside riverboat casino housing. Additional amenities include 117 hotel rooms, a restaurant, two covered parking garages as well as additional surface parking. In December 2010, the Company entered into an agreement to sell all of the assets and certain liabilities associated with the op! eration o! f Horizon Vicksburg.

Tropicana Aruba

The Company operates timeshare and rental units at Tropicana Aruba Resort & Casino (Tropicana Aruba), a casino resort und! er develo! pment in Noord, Aruba. This resort will have approximately 361 timeshare and rental units, an approximately 16,000 square foot permanent casino, two pools, a swim-up bar & grill, a fitness center and tennis courts, which will be located on approximately 14 acres near Eagle Beach.

Advisors' Opinion:

• [By Igor Greenwald]

  A majority stake in casino operator Tropicana Entertainment (TPCA) also began with a Chapter 11 restructuring.

  From January 1, 2000 to June 10, 2013, Icahn Enterprises has averaged a 20% annual return, multiplying investors' money nearly 12-fold. Berkshire-Hathaway (BRK-B) has managed only a triple over the same span.

source from Top Stocks For 2015:http://www.topstocksblog.com/top-10-casino-companies-to-buy-right-now-5.html

Top 5 Gas Stocks To Watch Right Now

Top 5 Gas Stocks To Watch Right Now: Kinder Morgan Management LLC (KMR)

Kinder Morgan Management, LLC is a limited partner in Kinder Morgan Energy Partners, L.P (KMP), and manages and controls its business and affairs pursuant to a delegation of control agreement. Kinder Morgan G.P., Inc., of which Kinder Morgan, Inc. indirectly owns all of the outstanding common equity, is the general partner of Kinder Morgan Energy Partners, L.P. (KMP). Kinder Morgan G.P., Inc., pursuant to a delegation of control agreement among the Company, Kinder Morgan G.P., Inc. and KMP, has delegated to the Company, to the fullest extent permitted under Delaware law and KMPs limited partnership agreement, all of its rights and powers to manage and control the business and affairs of KMP, subject to the general partners right to approve specified actions.

KPM is a pipeline limited partnerships in the United States. KMP owns an investment in or operates approximately 28,000 miles of pipelines and 180 terminals. Its pipelines transport products, such a s natural gas, crude oil, gasoline, and CO2, and its terminals store petroleum products and chemicals and handle materials like coal. Almost all of Kinder Morgan assets are owned by KMP, KMP operates in five business segments : Natural Gas Pipelines, Products Pipelines, CO2, Terminals and Kinder Morgan Canada.

Kinder Morgan is a transporter and marketer of carbon dioxide in North America. It delivers approximately 1.3 billion cubic feet per day of CO2 through about 1,300 miles of pipelines. It is an oil producer in Texas, producing over 55,000 barrels of oil per day at the SACROC Unit and the Yates Field in the Permian Basin. In addition to CO2 pipelines and oil producing fields, this business segment owns interests in and operates CO2 source fields, natural gas and gasoline processing plants, and a crude oil pipeline. Kinder Morgan owns and operates approximately 24,000 miles of gas pipelines in the Rocky Mountains, the Midwest and Texas. Thro! ugh its Products P ipelines business unit, it transports over two million barrels per day of gasoline, jet fuel, diesel, natural gas liquids and other fuels through more than 8,000 miles of pipelines. The Company also has approximately 50 liquids terminals in this business segment that store fuels and offer blending services for ethanol and other products.

Kinder Morgan have more than 180 terminals that store petroleum products and chemicals, and handle bulk materials like coal, petroleum coke and steel products. Kinder Morgan operates a number of pipeline systems and terminal facilities in Canada including the Trans Mountain pipeline, the Express and Platte pipelines, the Cochin pipeline, the Puget Sound and the Trans Mountain Jet Fuel pipelines, the Westridge marine terminal, the Vancouver Wharves terminal in British Columbia and the North Forty terminal in Edmonton, Alberta.

Advisors' Opinion:

• [By MONEYMORNING.COM]

  In a series of transactions, KMI will acquire all of Kinder Morgan Energy Partners LP (NYSE: KMP), Kinder Morgan Management LLC (NYSE: KMR), and El Paso Pipeline Partners LP (NYSE: EPB) for about $40 billion in stock and $4 billion in cash. KMI will also assume $27 billion in debt, bringing the total transaction value upwards of $70 billion.

• [By Aaron Levitt]

  For investors, the recent drop in all three shares — along with Kinder Morgan Management LLC (KMR) - have put them all near their 52-week lows and at some of the highest dividend yields not seen in years. At these prices, youre still getting strong dividend growth — about 5% for KMI — along with the chance to own the largest pipeline network in North America.

source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/top-5-gas-stocks-to-watch-right-now-2.html

Best Logistics Companies To Watch In Right Now

With shares of United Parcel Service (NYSE:UPS) trading around $90, is UPS an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

United Parcel Service is a package delivery company. The company delivers packages each business day for 1.1 million shipping customers to 7.7 million consignees in over 220 countries and territories. Last year, United Parcel Service delivered an average of 16.3 million pieces per day worldwide or a total of 4.1 billion packages. It serves the global market for logistics services, which include transportation, distribution, forwarding, ground, ocean and air freight, brokerage, and financing. United Parcel Service operates in three segments — U.S. Domestic Package, International Package, and Supply Chain & Freight.

United Parcel Service�� labor union woes still haven�� been resolved, according to the Wall Street Journal, and the shipping company is under pressure as the busy holiday season approaches. Teamsters-represented employees rejected two out of seven riders to their contract. The contract supplements that were rejected have to do with overtime pay, wages for part-time employees, and health-care. The Wall Street Journal said that UPS still has “a lot more work to do” before each rider on the contract that was approved in June is negotiated and UPS can move forward without the danger of potential labor disputes.

Best Freight Companies To Buy Right Now: Ebix Inc(EBIX)

Ebix, Inc. provides on-demand software and e-commerce solutions to the insurance industry. The company operates data exchanges, which connects multiple entities within the insurance markets and enables the participant to carry and process data from one end to another in the areas of life insurance, annuities, employee health benefits, risk management, workers compensation, and property and casualty (P&C) insurance. It is also involved in designing and deploying broker systems comprising three back-end systems consisting of eGlobal for multinational P&C insurance brokers; WinBeat for P&C brokers in the Australian and New Zealand markets; and EbixASP for the P&C insurance brokers in the United States. In addition, the company offers business process outsourcing services, which include certificate origination, certificate tracking, claims adjudication call center, and back office support. Further, it focuses on designing and deploying on-demand and back-end carrier systems, s uch as Ebix Advantage and Ebix Advantageweb targeted at small, medium, and large P&C carriers in the United States and internationally that operate in the personal, commercial, and specialty line areas of insurance. Additionally, Ebix, Inc. provides software development, customization, and consulting services to various companies in the insurance industry, such as carriers, brokers, exchanges, and standard making bodies. The company was formerly known as Delphi Systems, Inc. and changed its name to Ebix, Inc. in December 2003. Ebix, Inc. was founded in 1976 and is headquartered in Atlanta, Georgia.

Advisors' Opinion:

• [By Roberto Pedone]

  One software player that's rapidly moving within range of triggering a big breakout trade is Ebix (EBIX), which provides a series of application software products for the insurance industry ranging from carrier systems, agency systems and exchanges to custom software development for all entities involved in the insurance and financial industries. This stock has been slammed hard by the bears so far in 2013, with shares off by 28%.

  If you look at the chart for Ebix, you'll notice that this stock has been uptrending for the last month, with shares moving higher from its low of $9.25 to its intraday high of $11.65 a share. During that uptrend, shares of EBIX have been consistently making higher lows and higher highs, which is bullish technical price action. That move is quickly pushing shares of EBIX within range of trigger a major breakout trade that could push the stock into a massive gap down zone from last June.

  Traders should now look for long-biased trades in EBIX if it manages to break out above some near-term overhead resistance levels at $11.74 to $12 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 1.06 million shares. If that breakout triggers soon, then EBIX will set up to re-fill some of its previous gap down zone from June that started near $20 a share. Some possible upside targets if EBIX gets into that gap with volume are $14 to $16 a share.

  Traders can look to buy EBIX off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $10.87 a share or around more near-term support at $10.39 a share. One can also buy EBIX off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Best Logistics Companies To Watch In Right Now: P & F Industries Inc.(PFIN)

P&F Industries, Inc., through its subsidiaries, manufactures and sells tools and hardware products in the United States. The company operates in two segments, Tools and Other Products (Tools) and Hardware and Accessories (Hardware). The Tools segment manufactures, imports, and sells pneumatic hand tools, primarily for the industrial, retail, and automotive markets. Its product line includes sanders, grinders, drills, saws, impact wrenches, and pavement breakers; compressor air filters; and pipe and bolt dies, pipe taps, wrenches, vises and stands, pipe and tubing cutting equipment, hydrostatic test pumps, and replacement electrical components for pipe cutting and threading machines. This segment sells its products under the Florida Pneumatic, Universal Tool, ATP, Thaxton, THOR, and Eureka brand names to distributors, retailers, and private label customers through in-house sales personnel and manufacturers' representatives. The Hardware segment manufactures and imports door , window, and fencing hardware, including rollers, hinges, window operators, sash locks, custom zinc castings, and door closers. This segment also manufactures and imports interior wood and iron stair components, and related accessories, as well as kitchen and bath hardware; and manufactures stair products and distributes staircase components. Its products are sold through in-house sales personnel and manufacturers? representatives to distributors, retailers, and OEM customers. The company was founded in 1959 and is based in Melville, New York.

Advisors' Opinion:

• [By Monica Gerson]

  P&F Industries (NASDAQ: PFIN) is expected to report its quarterly results.

  INSYS Therapeutics (NASDAQ: INSY) is projected to report its Q1 earnings at $0.28 per share on revenue of $45.63 million.

Best Logistics Companies To Watch In Right Now: Interface Inc (TILE)

Interface, Inc., incorporated on August 28, 1981, is engaged in the business of design, production and sales of modular carpet, also known as carpet tile. The Company market modular carpet in over 110 countries under the brand names Interface and FLOR. The Company�� principal geographic markets are the Americas, Europe and Asia-Pacific. The Company manufactures carpet at two locations in the United States and at facilities in the Netherlands, the United Kingdom, Thailand and China. The Company distributes its product through two primary channels direct sales to end users, and indirect sales through independent contractors or distributors. In August 2012, the Company sold its Bentley Prince Street business segment to an affiliate of Dominus Capital, L.P.

The Company�� modular carpet system, which is marketed under the global brands Interface and Heuga, utilizes carpet tiles cut in precise, dimensionally stable squares (usually 50 cm x 50 cm) or rectangles to produce a floorcovering that combines the appearance and texture of traditional soft floorcovering with the advantages of a modular carpet system. The Company�� GlasBac technology employs a fiberglass-reinforced polymeric composite backing that provides dimensional stability and reduces the need for adhesives or fasteners. The Company�� also make carpet tiles with a backing containing post-industrial and/or post-consumer recycled materials, which we market under the GlasBacRE brand. The Company also manufactures and sells two-meter roll goods that are structure-backed and offer many of the advantages of both carpet tile and broadloom carpet. The Company also sells its TacTiles carpet tile installation system, along with a range of adhesives and products for carpet installation and maintenance that are manufactured by a third party.

Advisors' Opinion:

• [By Rex Moore]

  But today Jim's company is the largest craft brewer in the nation, with almost 1% of total beer sales. Many at the recent Craft Brewers Conference count Boston Beer among their most-admired companies. Our Rex Moore took on the tough assignment of covering the conference, and asked about other companies these brewers learned from. Today, New Belgium Brewing CEO Kim Jordan talks about Patagonia, Herman Miller (NASDAQ: MLHR  ) , and Interface (NASDAQ: TILE  ) .

• [By Seth Jayson]

  Interface (Nasdaq: TILE  ) reported earnings on April 24. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended March 31 (Q1), Interface missed estimates on revenues and missed estimates on earnings per share.

Best Logistics Companies To Watch In Right Now: On Track Innovations Ltd (OTIV)

On Track Innovations Ltd. (OTI) designs, develops and markets solutions based on its secure contactless microprocessor-based smart card technology to address the needs of a range of markets. The Company�� products combine the benefits of both microprocessors and contactless cards. In addition to contactless microprocessor-based smart cards, it also sells products that are based on other card technologies. The Company has focused on the development of its technologies and its products based on its technological platform that consists of smart cards, smart card readers, software tools and secure communication technology. As of December 31, 2012, it offers three lines of solutions, each of which constitutes a complete system, as well as components (such as smart cards and readers) that we sell to original equipment manufacturers (OEMs), for incorporation into their own products. OTI�� three vertical markets include Payment Solutions, Petroleum Systems and SmartID Solutions. Advisors' Opinion:

• [By Roberto Pedone]

   

   

  One under-$10 technology player that's starting to trend within range of triggering a major breakout trade is On Track Innovations (OTIV), which designs, develops and markets contactless microprocessor-based smart card solutions to customers in Africa, Europe, the Far East, the Americas and Israel. This stock has been red hot over the last three months, with shares up a whopping 134%.

  If you take a look at the chart for On Track Innovations, you'll notice that this stock has been trending sideways and consolidating over the last month and change, with shares moving between $2.70 on the downside and $3.74 on the upside. Shares of OTIV have now started to spike higher off some near-term support at $3 a share and it's quickly moving within range of triggering a major breakout trade above the upper-end of its recent sideways trading chart pattern.

  Traders should now look for long-biased trades in OTIV if it manages to break out above its 52-week high at $3.74 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average volume of 626,538 shares. If that breakout triggers soon, then OTIV will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $4.50 to $5.50 a share.

  Traders can look to buy OTIV off weakness to anticipate that breakout and simply use a stop that sits just below some key near-term support levels at $3.20 or at $3 a share. One can also buy OTIV off strength once it starts to clear its 52-week high at $3.74 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By Markman Advisors]

  Public companies leveraging their patent portfolios, (aka "patent plays"), are getting the market's attention. Companies such as Vringo (VRNG), ParkerVision (PRKR), MGT Capital (MGT), Worlds Inc. (WDDD.OB) and others have presented trading opportunities due to their volatility while retaining the chance for a big payoff to those investors who stay the course. Yet there exist viable patent plays that are still undiscovered. Some of these so called "plays," which are not getting enough attention, are actually real companies making and selling real products or services in contrast to pure patent monetization companies. Some known examples are Single Touch Interactive (SITO.OB) and Blue Calypso (BCYP.OB). This article is focused on another one of these patent plays, On Track Innovations Ltd. (OTIV).

Best Logistics Companies To Watch In Right Now: Empresa Nacional de Electricidad S.A. (EOC)

Empresa Nacional de Electricidad S.A., together with its subsidiaries, engages in the generation, transmission, production, and distribution of electricity in Chile, Argentina, Colombia, Peru, and Brazil. The company owns and operates hydroelectric, thermal, and wind power generation facilities. As of December 31, 2009, it owned and operated 29 generation facilities with an aggregate installed capacity of 5,650 megawatts in Chile; and had interests in 25 generation facilities with an aggregate installed capacity of 8,214 megawatts in Argentina, Colombia, and Peru. In addition, it provides engineering consulting services and operates a tunnel concession. The company was founded in 1943 and is headquartered in Santiago, Chile. Empresa Nacional de Electricidad S.A. is a subsidiary of Enersis S.A.

Advisors' Opinion:

• [By Garrett Cook]

  Utilities sector was the top decliner in the US market on Wednesday. Top losers in the sector included Huaneng Power International (NYSE: HNP), Companhia de Saneamento Basico do Estado de Sao Paulo (NYSE: SBS), and Empresa Nacional de Electricidad S.A. (NYSE: EOC).

• [By Garrett Cook]

  Utilities sector was the top decliner in the US market on Wednesday. Top losers in the sector included Huaneng Power International (NYSE: HNP), Companhia de Saneamento Basico do Estado de Sao Paulo (NYSE: SBS), and Empresa Nacional de Electricidad S.A. (NYSE: EOC).

Best Logistics Companies To Watch In Right Now: Oppenheimer Holdings Inc.(OPY)

Oppenheimer Holdings Inc., through its subsidiaries, operates as a middle-market investment bank and full service broker-dealer. It offers full-service brokerage services covering various investment alternatives, such as exchange-traded and over-the-counter corporate equity and debt securities, money market instruments, exchange-traded options and futures contracts, municipal bonds, mutual funds, and unit investment trusts. The company also provides financial and wealth planning services; margin lending; securities lending; and online equity investing and discount brokerage services. In addition, it offers asset management services for equity, fixed income, large-cap balanced, and alternative investments offered through vehicles, such as privately managed accounts, and retail and institutional separate accounts. Further, the company provides strategic advisory services and capital markets products; institutional equity sales and trading; equity research; equity options and derivatives; convertible bonds; and event driven sales and trading services. Additionally, it trades in non-investment grade public and private debt securities, mortgage-backed securities, sovereign and corporate debt, and distressed securities; provides fixed income research, public finance, and municipal trading services; and is involved in proprietary trading and investment activities. The company also participates in loan syndications and operates as underwriting agent in financing transactions; trades syndicated corporate loans in the secondary market; offers various trust services; and provides mortgage services to developers of commercial properties. It serves high-net-worth individuals and families, corporate executives, small and mid-sized businesses, endowments and foundations, and institutions in the United States, Europe, the Middle East, Asia, and South America. The company was founded in 1977 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Ben Rooney]

  Tamayo then handed that information over to Vladimir Eydelman, a stock broker at Oppenheimer (OPY) and Morgan Stanley (MS). Eydelman in turn used it to trade stocks for Tamayo and other customers.

• [By Hilary Kramer]

  With this news, some Wall Street firms finally ��albeit a bit late ��jumped on the ICPT bandwagon.� Citigroup (C) raised its target to $400, stating that its market cap (at the time $5.4 billion) didn�� reach the opportunity for these liver disease treatments.� They estimated that the OCA could exceed a $5 billion sales level.� Oppenheimer (OPY) also raised its target to $360 while Bank of America/Merrill’s (BAC) target is set at $872, the only one not yet exceeded with the most recent move.

Top 10 Quality Companies For 2016

Top 10 Quality Companies For 2016: Old Republic International Corporation(ORI)

Old Republic International Corporation, through its subsidiaries, provides various insurance and mortgage guaranty products in North America. The company operates in three segments: General Insurance, Mortgage Guaranty, and Title Insurance. The General Insurance segment provides liability insurance coverages to businesses, government, and other institutions in commercial construction, forest products, energy, general manufacturing, and financial services industries; and transportation, including trucking and general aviation industries. It provides various insurance products, such as automobile extended warranty, aviation, commercial automobile insurance, general liability, home warranty, inland marine, travel accident, and workers? compensation, as well as liability coverage for claims arising from the acts of owners or employees, and protection for the physical assets of businesses. This segment also offers financial indemnity products, such as consumer credit indemnity , errors and omissions/directors and officers, guaranteed asset protection, and surety, as well as bonds that cover the exposures for losses of monies, or debt and equity securities due to acts of employee dishonesty. The Mortgage Guaranty segment insures first mortgage loans, primarily on residential properties incorporating one-to-four family dwelling units to mortgage bankers, brokers, commercial banks, and savings institutions. The Title Insurance segment provides lenders' and owners' title insurance policies to real estate purchasers and investors based upon searches of the public records. It also provides escrow closing and construction disbursement services; and real estate information products, national default management services, and services related to real estate transfers and loan transactions. Old Republic International Corporation markets its product! s directly, as well as through insurance agents and brokers. The company was founded in 1887 and is based in Chi cago, Illinois.

Advisors' Opinion:

• [By Lawrence Meyers]

  The part I like the most is that WGL sells energy credits and carbon offsets to retail customers. The company makes good money on these elements, selling to customers who just like to feel good about how they are "helping the environment". WGL has a long history as an energy company and has paid a dividend for 37 years. It currently pays 4.3% annually.

  Old Republic International (ORI)

  The next of our dividend stocks is one you may have heard of: Old Republic International (ORI). Old Republic started back in 1887 and is an insurance company that offers a huge array of products. A lot of insurance products are very high margin, and Old Republic has mastered the art of selling these. Extended Automobile Warranty, Home Warranty an Travel Accident Insurance are great segments to be playing in.

• [By Marc Bastow]

  Insurance underwriting company Old Republic (ORI) raised its quarterly dividend 5.8% to 18 cents per share, payable on Dec. 16 to shareholders of record as of Dec. 4.
  ORI Dividend Yield: 4.28%

• [By Ben Levisohn]

  Its big day has also boosted other insurers. Radian Group (RDN) has risen 7.2% to $14.39, while Old Republic International (ORI) has advanced 2.1% to $15.24, Genworth Financial (GNW) is up 3.6% at $13.41 and MBIA Inc. (MBI) has jumped 4.3% to $10.76.

• [By Holly LaFon]

  Prem Watsa is renowned for his long track record of outstanding returns using Buffett-style value investing through his worldwide insurance and reinsurance company, Toronto-based Fairfax Financial Holdings. His five-year cumulative is 176.4%, compared to 12.2% for the S&P 500. Most recently, he made headlines for making a large contrarian bet on Research In Motion (RIMM) and joining its board in his first activist investing foray. In the fo! urth quar! ter, he added to this position. He also added to his positions in Citigroup Inc. (C), Old Republic Corp. (ORI) and Johnson & Johnson (JNJ) and dramatically reduced one of his largest holdings, Dell (DELL). As a Ben Graham devotee, Watsa looks past short-term fluctuations in price to the underlying strength of a business. His stance on the economy, as of September and October 2011, was that he believed the U.S. was showing Depression-level interest rates and deficits, but he still liked some stocks and would hedge his exposure, he told CFA Institute Magazine.

source from Top Stocks For 2015:http://www.topstocksblog.com/top-10-quality-companies-for-2016.html

Top 10 Biotech Companies To Own For 2015

Seattle Genetics, Inc. (NASDAQ:SGEN) is a big deal today, and Needham & Company says it could be the next big thing in the pharmaceutical space.

Seattle Genetics is a biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for cancer.

Its product candidate, ADCETRIS or brentuximab vedotin is approved by United States Food and Drug Administration (FDA) in two indications: the treatment of patients with Hodgkin lymphoma, and for patients with systemic anaplastic large cell lymphoma (s ALCL).

ADCETRIS is an antibody-drug conjugate, or ADC, comprising an anti-CD30 monoclonal antibody attached by a protease-cleavable linker to a microtubule disrupting agent, monomethyl auristatin E (MMAE), utilizing its technology.

Top 5 Cheapest Companies For 2016: PTC Therapeutics Inc (PTCT)

PTC Therapeutics, Inc., incorporated on March 31, 1998 , is a biopharmaceutical company focused on the discovery and development of orally administered, small-molecule drugs that target post-transcriptional control processes. The Company�� lead product candidate includes ataluren, which is used for the treatment of patients with genetic disorders that arise from a type of genetic mutation known as a nonsense mutation. Ataluren is in late stage clinical development for the treatment of Duchenne muscular dystrophy caused by nonsense mutations (nmDMD) and cystic fibrosis caused by nonsense mutations (nmCF).

Ataluren is orally administered small-molecule compound that targets nonsense mutations. The Company is engaged in the development of ataluren for the treatment of genetic disorders in, which a nonsense mutation is the cause of the disease. Genetic tests are available for many genetic disorders, including Duchenne muscular dystrophy and cystic fibrosis, to determine if the underlying cause is a nonsense mutation. The EMA has designated ataluren as an orphan medicinal product for the treatment of nmDMD and nmCF. During the year ended December 31, 2012, the Phase III clinical trial completed. The Company�� Ataluren clinical trials in patients with nonsense mutation genetic disorders include Ataluren for nmDMD: Phase 2b clinical trial complete; Confirmatory Phase III clinical trial initiated, and Ataluren for nmCF: Phase III trial completed.

Advisors' Opinion:

• [By John Kell]

  PTC Therapeutics Inc.(PTCT) said the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a negative opinion on the biopharmaceutical company’s marketing authorization application for its muscular dystrophy treatment. Shares slumped 21% to $20.60 in premarket trading.

Top 10 Biotech Companies To Own For 2015: Biota Pharmaceuticals Inc (BOTA)

Biota Pharmaceuticals, Inc., formerly Nabi Biopharmaceuticals, incorporated on March 14, 1969, is an anti-infective drug development company, with key expertise in respiratory diseases, particularly influenza. Biota developed the neuraminidase inhibitor, zanamivir, subsequently marketed by GlaxoSmithKline as Relenza. The Company�� researches include a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease and Hepatitis C (HCV) virus infections. In addition, Biota and Daiichi Sankyo co-own a range of second generation influenza anti-virals, of which the lead product lnavir, is approved for marketing in Japan.

The Company�� products include Zanamivir, Inavi, Phoslyra, BioStar OIA FLU and BioStar OIA FLU A/B. Zanamivir is a neuraminidase inhibitor for the treatment and prophylaxis of influenza marketed as Relenza by GlaxoSmithKline. Inavi (laninamivir) is a neuraminidase inhibitor marketed by Daiichi Sankyo in Japan. Phoslyra is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). BioStar OIA FLU and BioStar OIA FLU A/B are influenza diagnostic tests, which are marketed by Inverness Medical as part of their BioStar product range.

Relenza is delivered directly to the primary site of infection on the lungs, using a Disk Inhaler device. Relenza is approved in over 50 countries for the treatment of influenza, including in the United States, the European Union, Japan and Australia. Relenza is also approved for use as a preventative (prophylactic) treatment against influenza. Inavir is approved for sale in Japan for the treatment of influenza in adults and children. Daiichi Sankyo has applied to sell Inavir in Japan for the prevention of influenza.

PhosLo and Phoslyra are different dose forms of calcium acetate; a phosphate binder approved in multiple countries for the control of hyperphosphatemia (high serum phosphate) in patients with end stage renal disease (ESRD). PhosLo and Pho! slyra were sold to Fresnius Medical Care. Biota, together with its Japanese based partner, Daiichi Sankyo, have developed an inhaled antiviral compounds for influenza, called long acting inhaled neuraminidase inhibitors (LANI). Biota's human rhinovirus (HRV) drug for the prevention and treatment of the causes of the common cold, BTA798, has completed Phase I, Phase IIa and Phase IIb clinical trials.

Advisors' Opinion:

• [By gurujx]

  Biota Pharmaceuticals Inc (BOTA) Reached the 3-year Low of $2.42

  The prices of Biota Pharmaceuticals Inc (BOTA) shares have declined to close to the 3-year low of $2.42, which is 93.3% off the 3-year high of $34.92.

Top 10 Biotech Companies To Own For 2015: Exelixis Inc.(EXEL)

Exelixis, Inc., a biotechnology company, develops small molecule therapies for the treatment of cancer. It focuses on developing Cabozantinib, an inhibitor of tumor growth, metastasis, and angiogenesis that target MET, VEGFR2, and RET, which are key kinases involved in the development and progression of various cancers. The cabozantinib is in Phase III clinical trial for the treatment for medullary thyroid cancer. The company also engages in various clinical programs for cabozantinib focused on the treatment of metastatic castration-resistant prostate cancer, ovarian cancer, breast cancer, renal cell carcinoma, non-small cell lung cancer, hepatocellular cancer, and melanoma. In addition, Exelixis, Inc. involves in developing a portfolio of other novel compounds to address serious unmet medical needs through collaborations with various pharmaceutical and biotechnology companies, including Bristol-Myers Squibb Company, sanofi-aventis, Genentech, Inc., Boehringer Ingelheim Gm bH, and GlaxoSmithKline and Daiichi Sankyo Company Limited. Its products under development through collaborations include XL475, XL281, XL139, and XL413 inhibitors; ROR antagonists; therapies targeted against LXR, a nuclear hormone receptor implicated in various cardiovascular and metabolic disorders; XL147, XL765, and isoform-selective PI3K inhibitors; XL518, a small-molecule inhibitor of MEK; sphingosine-1-phosphate type 1 receptor; XL880 inhibitor; and therapies targeted against the mineralocorticoid receptor, a nuclear hormone receptor implicated in various cardiovascular and metabolic diseases. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in South San Francisco, California.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Equities Trading DOWN
  Shares of Exelixis (NASDAQ: EXEL) were down 36.18 percent to $4.11 after the company issued an update on ongoing COMET-1 phase 3 pivotal trial in men with metastatic castration-resistant prostate cancer. Stifel Nicolaus lowered the price target on the stock from $11.00 to $9.00.

Top 10 Biotech Companies To Own For 2015: GW Pharmaceuticals PLC (GWPRF)

GW Pharmaceuticals plc is a United Kingdom-based company. The Company is engaged in the research, development and commercialization of a range of cannabinoid prescription medicines to meet patient needs in a range of medical conditions. The Company is developing a portfolio of cannabinoid medicines, of which the main product is Sativex, an oromucosal spray for the treatment of Multiple Sclerosis (MS) symptoms, cancer pain and neuropathic pain. The Company operates in three segments: Sativex Commercial, Sativex Research and Development and Pipeline Research and Development. The Company�� wholly owned subsidiaries include GW Pharma Limited, G-Pharm Limited, Cannabinoid Research Institute Limited, Guernsey Pharmaceuticals Limited and GWP Trustee Company Limited. Advisors' Opinion:

• [By Ben Levisohn]

  But, as the Huffington Post points out, most of the companies that stand to benefit are very small–they make micro caps look big–trade over the counter–good bye liquidity. That includes transaction-processing company MediSwipe (MWIPD), GreenGro Technologies (GRNH) Medbox (MDBX), which makes dispenser for high-risk drugs, and GW Pharmaceuticals (GWPRF).

Top 10 Biotech Companies To Own For 2015: Puma Biotechnology Inc (PBYI)

Puma Biotechnology, Inc., incorporated in April 2007, is a development-stage biopharmaceutical company that acquires and develops products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. As of December 31, 2011, the Company licensed three drug candidates: PB272 (neratinib (oral)), which the Company is developing for the treatment of advanced breasts cancer patients and gastric cancer patients; PB272 (neratinib (intravenous)), which the Company is developing for the treatment of advanced cancer patients, and PB357.

PB272 (neratinib (oral))-Breast Cancer

Neratinib is a potent irreversible tyrosine kinase inhibitor, or TKI, that blocks signal transduction through the epidermal growth factor receptors (EGFRs), HER1, HER2 and HER4. The Company's initial focus is on the development of neratinib as an oral treatment of patients with HER2 positive metastatic breast cancer.

PB272 (neratinib (intravenous))

The Company develops neratinib as an intravenously administered agent. In pre-clinical studies the intravenous version of neratinib resulted in higher exposure levels of neratinib in pre-clinical models.

PB357

PB357 is an orally administered agent that is an irreversible TKI that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. PB357 is structurally similar to PB272. Pfizer completed single dose Phase I trials of PB357. The Company is evaluating PB357.

The Company competes with Genentech, GlaxoSmithKline, Roche, Boehringer Ingelheim, Takeda, Array Biopharma and Ambit Biosciences.

Advisors' Opinion:

• [By George Budwell]

  With that being said, developmental biotechs that fall hard on news could be worth taking a look at because they may have fallen for all the wrong reasons. Puma Biotechnology (NYSE: PBYI  ) , for example, plummeted by 25% about a month ago after reporting mid-stage clinical trial data for the company's flagship cancer drug PB272 (neratinib).

• [By Anna Prior]

  Puma Biotechnology Inc.(PBYI) reported positive top-line data from the Phase II clinical trial of the biopharmaceutical company’s investigational drug PB272 for the neoadjuvant treatment of breast cancer.

• [By Tom Rojas and Maria Armental var popups = dojo.query(".socialByline .popC"); ]

  Puma Biotechnology Inc.(PBYI) said its investigational breast-cancer treatment showed a 33% improvement in disease-free survival over a placebo in a Phase 3 study. Share surged 271% to $218 premarket.

• [By Ben Levisohn]

  After big rallies by biotech stocks, the folks at Weeden wondered if the rally getting overdone.�UBS analyst Matthew Roden and team think biotech stocks like Gilead Sciences�(GILD), Celgene�(CELG),�Vertex Pharmaceuticals (VRTX),�Puma Biotechnology (PBYI) and Achillion Pharmaceuticals (ACHN) can keep running. They explain why:

Top 10 Biotech Companies To Own For 2015: Epizyme Inc (EPZM)

Epizyme, Inc., incorporated on November 1, 2007, is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers. The Company systematically identify the genetic alterations that create cancer causing genes, called oncogenes, select patients in whom the identified genetic alteration is found and then design small molecule therapeutics to inhibit the oncogene. The clinical development plan for each of its product candidates is directed towards patients with a particular genetically defined cancer.The Company is conducting a Phase I clinical trial of its advanced product candidate, EPZ-5676, an inhibitor targeting the DOT1L HMT, for the treatment of mixed lineage leukemia (MLL-r). The Company has identified its two lead product candidates using its product platform.

EPZ-5676-DOT1L Inhibitor

EPZ-5676 is an intravenously administered small molecule inhibitor of DOT1L. The Company is developing EPZ-5676 for the treatment of MLL-r, an aggressive subtype of the two most common forms of acute leukemia, ALL and AML. Patients with MLL-r are routinely diagnosed with existing technologies that are commonly used in clinical setting. The Company�� Phase 1 clinical trial of EPZ-5676 is an open label, multicenter trial that has two phases.

EPZ-6438-EZH2 Inhibitor

The Company is developing EPZ-6438 as an orally available small molecule inhibitor of EZH2 for the treatment of non-Hodgkin lymphoma patients who have an oncogenic point mutation in EZH2. EZH2 is an HMT that can become oncogenic and cause non-Hodgkin lymphoma and a range of other solid tumors. Two types of non-Hodgkin lymphoma, diffuse large B-cell lymphoma of germinal-center origin, or DLBCL, and follicular lymphoma, or FL, are particularly associated with an EZH2 point mutation. There are no therapies approved specifically for the treatment of cancer associated with an EZH2 point mutation.

Advisors' Opinion:

• [By John Udovich]

  On Tuesday, small cap biopharmaceutical company Epizyme Inc (NASDAQ: EPZM) surged 75.56% after the company announced that its�EPZ-5676, a DOT1L inhibitor for acute leukemias, had reached its proof-of-concept milestone, meaning its worth taking a closer look at the stock as well as look at the share performance of cancer stocks like large cap Celgene Corporation (NASDAQ: CELG) and small caps�Dendreon Corporation (NASDAQ: DNDN) and Geron Corporation (NASDAQ: GERN).

Top 10 Biotech Companies To Own For 2015: Tauriga Sciences Inc (TAUG)

Tauriga Sciences, Inc., formerly Immunovative, Inc., incorporated on April 18, 2001, is a development-stage company. The Company along with Constellation Diagnostics, Inc. (Constellation) focuses on establishing a joint venture partnership to develop and commercialize a imaging-based diagnostic technology for use in predictive and preventative oncology.

The Company has rights to commercialize AlloStim and AlloVax. As of March 31, 2013 the Company did not have any revenues.

Advisors' Opinion:

• [By Peter Graham]

  Small cap marijuana stocks IMD Companies Inc (OTCMKTS: ICBU), Tauriga Sciences Inc (OTCMKTS: TAUG), ML Capital Group Inc (OTCBB: MLCG) and Lexaria Corp (OTCMKTS: LXRP) are aiming to give investors a high with their latest news. However, only one of these small cap marijuana stocks appears to be the subject of minor paid promotion or investor relations type of activities. So will investors and traders alike get a high off of these small caps? Here is a quick reality check:

• [By Peter Graham]

  Small cap health care or personal care stocks Axxess Pharma Inc (OTCMKTS: AXXE), Radiant Creations Group Inc (OTCBB: RCGP) and Tauriga Sciences Inc (OTCMKTS: TAUG) have recently been attracting attention in various investment newsletters or in investor alerts. Some of the attention may have to do with paid promotions that two of these small caps have been the subject of. So how healthy are these three small cap health care or personal care orientated stocks? Here is a checkup:

Hot Railroad Companies To Buy For 2016

Hot Railroad Companies To Buy For 2016: Medical Action Industries Inc.(MDCI)

Medical Action Industries Inc. develops, manufactures, markets, and supplies various disposable medical products primarily in the United States. It offers custom procedure trays that include orthopedic, cath lab/radiology, labor and delivery, cardiac, ophthalmology, tissue procurement, neurology, robotic, gynecological, vascular, urology, cosmetic/plastic surgery, anesthesia/pain, bariatric, and general/other trays; minor procedure kits and trays, such as central line dressing, suture removal, laceration, incision and drainage, general purpose instrument, wound dressing change, sharp debridement, venipuncture, ear and ulcer syringes, trach care, and irrigation trays, as well as razor and shave prep kits, piston syringes, and I.V. start kits; and operating room disposables and sterilization products comprising surgical marking pens, needle counters, light shields, convenience kits, surgical headwear and shoe covers, isolation gowns, instrument protection, eye-shields, sutur e boots, basin separators, reel cutters, patient aids, crutches, walkers, canes, patient slippers, O.R. basins, magnetic drapes, guide wire bowls, bowie dick test packs, vessel loops, anti-fog solutions, heat sealers, and tray liners. The company also provides patient bedside products consisting of wash basins, bedpans, pitchers and carafes, urinals, emesis basins, soap dishes, medicine and denture cups, tumblers, sitz baths, service trays, and perineal bottles; dressings and surgical sponges, which include burn dressings, sponge counting systems, elastic nets, and bandage rolls; containment systems for medical waste, such as waste solidifier and spill cleanup kits, and equipment dust and sterility maintenance covers; and laboratory products comprising petri dishes, containers, collectors, calculi strainers, and vials. It sells its products primarily to acute c! are facilities through a network of direct sales personnel. The company was founded in 1977 and is headquartered in Brentwood, New York.

Advisors' Opinion:

• [By Thomas Scarlett]

  The medical device market keeps expanding, as new technologies are constantly introduced and the need for health care by the U.S. population keeps growing. One of the most dynamic companies in this sector is Medical Action Industries Inc. (NASDAQ: MDCI).
  
  Medical Action is a manufacturer and distributor of disposable medical devices, and a leader in many of the markets where it competes. Its products are marketed primarily to acute care facilities in domestic and certain international markets. The company has recently expanded its target market to include physician, dental and veterinary offices, out-patient surgery centers, long-term care facilities and laboratories.
  
  Medical Action’s products are marketed nationally by its direct sales personnel and extensive network of health care distributors. The firm has preferred vendor agreements with several national and regional distributors, as well as sole and multi-source agreements with group purchasing org anizations.
  
  Concerns about contamination, infection, or imperfection in medical supplies have never been higher. Medical Action has earned a solid reputation for producing reliable, well-crafted medical tools.
  
  The company has moved to a dominant position in the operating room supplies market in just a few years. Among the company's products are sutures, laparotomy sponges, operating room basins and various sterility monitoring products. It also offers clinical care market products, which include custom procedure trays and minor procedure kits. Medical Action has a strong record of developing new products and getting them approved by the Food and Drug Administration in a timely manner.
  
  As the population ages and more Americans are covered by Medicare, while younger Americans have more access under the! Affordab! le Care Act, the earnings potential of well-managed health care providers and the companies that supply them with tools will only grow.
  
  The company's first-qu

• [By Roberto Pedone]

  Another under-$10 health care player that's starting to move within range of triggering a major breakout trade is Medical Action Industries (MDCI), which develops, manufactures, markets and supplies a variety of disposable medical products. This stock has been on fire so far in 2013, with shares up sharply by 129%.

  If you take a look at the chart for Medical Action Industries, you'll notice that this stock has been trending sideways and consolidating for the last month and change, with shares moving between $5.84 on the downside and $6.76 on the upside. Shares of MDCI are now starting to spike higher right off its 50-day moving average of $6.09 a share, and it's quickly moving within range of triggering a major breakout trade above the upper-end of its sideways trading chart pattern.

  Market players should now look for long-biased trades in MDCI if it manages to break out above its 200-day moving average at $6.67 a share and then once it takes out some more key overhead resistance levels at $6.76 to $7.13 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 98,989 shares. If that breakout hits soon, then MDCI will set up to re-test or possibly take out its next major overhead resistance levels at $9.50 to $10 a share.

  Traders can look to buy MDCI off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels a $5.84 to $5.50 a share. One can also buy MDCI off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

source from Top Stocks For 2015:http://www.topstocksblog.! com/hot-r! ailroad-companies-to-buy-for-2016.html

JPMorgan Chase Stock Is Trouncing the Dow

The Dow Jones Industrial Average (DJINDICES: ^DJI  ) is up slightly, continuing its slow but steady rise. JPMorgan Chase (NYSE: JPM  ) stock is pulling the Dow higher, as it appears shareholders have rejected the vote to split the roles of chairman and CEO. As of 1:25 p.m. EDT the Dow is up 72 points, or 0.47%, while the S&P 500 (SNPINDEX: ^GSPC  ) is up 0.38%.

The markets are continuing their slow rise as investors anticipate a clearer idea of when the Federal Reserve will slow or stop its quantitative-easing program. They will get a couple of reads on that tomorrow, starting with Fed Chairman Ben Bernanke's testimony before Congress' Joint Economic Committee at 10 a.m. EDT. Then, at 2 p.m. EDT, the minutes of the May 1 Open Market Committee meeting will be released. While a statement from the FOMC was released on the afternoon of the meeting, investors are hoping to see in detail the arguments that were brought up both for and against quantitative easing in order to try to predict the Fed's future actions.

In bigger news, JPMorgan is up 1.8%, as it appears that the company's shareholders have voted against splitting the roles of chairman and CEO, both of which are currently occupied by Jamie Dimon. While the vote is nonbinding, many analysts are worried that Jamie Dimon would leave JPMorgan if the position were split.

Advocates argue that companies should have independent chairmen, as the board should be supervisory and oversee the work of the CEO. They also argue that having both roles filled by one person is a conflict of interest. That said, the most notable company with a combined CEO and chairman role is Berkshire Hatheway (NYSE: BRK-B  ) , with Warren Buffett holding both spots. Buffett is an exceptional leader who has shown that he is uniquely qualified to hold both roles. While an independent chairman of the board sounds good in theory, in practice, too many boards and chairmen simply defer to management and rubber-stamp its actions. Companies need board members that will take a stand when they see dubious actions and dig deeper to find problems before they become disasters.

Given the "London Whale" scandal, a new robosigning lawsuit, and continued regulatory pressure, Jamie Dimon seems the best leader to pull the bank through its troubles. Even Warren Buffett has said: "I'm 100% for Jamie. I couldn't think of a better chairman."

It remains to be seen what will happen, but it looks like Jamie is staying with the bank. With big finance firms still trading at deep discounts to their historical norms, investors everywhere are wondering if this is the new normal or if finance stocks are a screaming buy today. The answer depends on the company, so to help you figure out whether JPMorgan is a buy today, check out The Motley Fool's premium research report on the company. Click here now for instant access!

#pitch{ margin-bottom: 15px; }

More Expert Advice from The Motley Fool

The Motley Fool's chief investment officer has selected his No. 1 stock for the next year. Find out which stock in our brand-new free report: "The Motley Fool's Top Stock for 2013." I invite you to take a copy, free for a limited time. Just click here to access the report and find out the name of this under-the-radar company.

How Effective Are Pipeline Leak Detection Systems?

Recent pipeline spills, such as ExxonMobil's (NYSE: XOM  ) not-so-minor crude oil spill in Arkansas last month, have raised important questions about the effectiveness of pipeline operators' leak detection systems.

These issues are especially pertinent for TransCanada's (NYSE: TRP  ) proposed Keystone XL pipeline, which would link production from Alberta's oil sands to U.S. Gulf Coast refiners. With that in mind, let's take a closer look at how leak detection systems work and how effective they are.

A primer on leak detection systems
Though pipeline companies use a wide array of techniques to detect leaks, remote leak detection technology is the most comprehensive, offering real-time, nonstop monitoring along the line's route.  

After purchasing leak detection technology from specialist firms, most pipeline operators customize their system to better serve their needs on a project-by-project basis. In most cases, sensors are placed along a pipeline, where they gauge such important metrics as temperature, pressure, and flow rates.  

This information is relayed to an operator's control room, where it has a dual purpose -- to record how much oil has been delivered to the company's customers and to monitor the line for leakages or ruptures.  

When the sensing technology detects something unusual, such as a sharp change in pressure or flow rates, it sets off an alarm. The company's personnel then conduct additional tests to figure out whether or not the unusual activity signals a leak.  

In many cases, however, alarms can be triggered by non-threatening activity. For instance, the buildup of bubbles within the pipeline's flow -- known as column separation -- often triggers false alarms and appears exactly as a leak would to the remote operators in the control room.  

In fact, some operators may get so used to false alarms that they may become dismissive of real ones. For instance, consider the rupturing of an Enbridge (NYSE: ENB  ) pipeline in July 2010, which discharged more than a million gallons of dilbit crude into Michigan's Kalamazoo River in what was the first major bituminous crude spill into a U.S. waterway.

Enbridge spill highlights issues with leak detection systems
As InsideClimate News reported in a painstakingly thorough and engaging investigation of the Enbridge spill, for which it was awarded the Pulitzer Prize for national reporting, the Enbridge accident was riddled with misunderstandings that led to an unfortunate outcome.

At the time the pipeline ruptured, the company's controllers were monitoring data from multiple lines, while also working 12-hour shifts. At the first sign of danger -- the moment pipeline 6B ruptured -- numerous alarms were triggered.  

Yet control room and other personnel dismissed the warnings as false alarms triggered because of column separation. It took them 17 hours to figure out they had a spill on their hands. Once you consider the inherent problems with remote sensing, though, it's harder to assign blame to the operators.

After all, they're highly trained, yet still fallible, human beings who are doing the best they can with what they're given -- an imperfect technology. Richard Kuprewicz, president of Accufacts, a consulting firm specializing in pipelines, summed up this tricky dilemma:

If you get a thousand [false alarms] a month, what happens when you get a big [real] one? How do you tell the difference? You can't.

Final thoughts
The bottom line seems to be that remote leak detection technology works as intended only part of the time, despite the millions of dollars the industry invests each year to improve it. Pipelines that have oil flowing at a constant rate are more likely to find such technology beneficial. On the other hand, pipelines with variable flow rates -- a group that includes Keystone XL, as well as most new U.S. pipelines -- are more likely to encounter problems with leak detection.  

The unfortunate reality is that no silver-bullet solution to detect all oil spills consistently and reliably exists today. Even companies with top-notch leak detection systems and experienced control-room personnel have to face the very real risk that some leaks will go unnoticed.

But don't let imperfect leak detection systems turn you off to investing in pipeline companies. Though they do face risks, they're generally stable businesses and are aptly positioned to benefit from the massive infrastructure build-out currently under way in the US. Enterprise Products Partners, the nation's largest publicly traded energy partnership, is at the forefront of this trend and is investing heavily in pipeline infrastructure that will serve the nation's energy companies for decades into the future. To help investors decide whether Enterprise Products Partners is a buy or a sell today, click here now to check out The Motley Fool's brand-new premium research report on the company.

13 Best & Worst 529 College Savings Plans of 2014: Morningstar

With college costs ever rising, parents are always looking for ways to make sure they have enough money put away so their kids can get an education.

One way to do that is to invest in 529 plans, which allow for tax-deductible savings that grow in a tax-deferred manner.

529 plans were added to the IRS code more than 10 years ago, with assets in 84 plans nationwide now totaling $200 billion. In 2013, the plans grew 20% over the prior year.

Morningstar recently released its ratings of the 84 plans. Each was assigned to the Gold, Silver, Bronze or Negative category.

The plans were ranked in these five areas: Process, Performance, Price, Parent and People. To get rated as Gold, for example, Morningstar says the plans must meet the “highest-conviction recommendations and stand out as best of breed for their ability to help college savers meet their goals.”

(Related: 30 Best Paying College Majors: 2014)

We’ve listed the plans that merited the top two ratings and those that were deemed to be at the bottom. Of course, the vast majority received a Neutral rating.

We’ve included the rankings by state in terms of 529-plan assets under management. Virginia, with more than $46 billion in assets under management, has by the far the highest level of assets when it comes to college savings.

Check out the Best and Worst 529 College Savings Plans:

THE BEST

1. Maryland College Investment Plan Direct

Rating: Gold

Program Manager: T. Rowe Price

State’s Total 529 AUM: $3.8 billion/Rank: 18th

2. T. Rowe Price College Savings Plan Direct – Alaska

Rating: Gold

Program Manager: T. Rowe Price

State’s Total 529 AUM: $6.07 billion/Rank: 10th

3. The Vanguard 529 College Savings Plan Direct – Nevada

Rating: Gold

Program Manager: UPromise Investments

State’s Total 529 AUM: $12.7 billion/Rank: 3rd

4. Utah Educational Savings Plan Direct

Rating: Gold

Program Manager: Utah Educational Savings Plan

State’s Total 529 AUM: $6.7 billion/Rank: 7th

5. CollegeAdvantage 529 Savings Plan Direct – Ohio

Rating: Silver

Program Manager: Ohio Tuition Trust Authority

State’s Total AUM: $7.7 billion/Rank: 5th

6. CollegeAmerica Advisor – Virginia

Rating: Silver

Program Manager: American Funds

State’s Total AUM: $46.7 billion/Rank: 1st

7. iShares 529 Plan Advisor – Arkansas

Program Manager: UPromise Investments

State’s Total AUM: $485.5 million /Rank: 36th

8. Michigan Education Savings Program Direct

Rating: Silver

Program Manager: TIAA Tuition Financing

Top Asian Stocks To Buy For 2016

State’s Total AUM: $3.9 billion/Rank: 14th

9. ScholarShare College Savings Plan Direct – California

Rating: Silver

Program Manager: TIAA Tuition Financing

State’s Total AUM: $5.5 billion/11th

THE WORST

10. CollegeBound Fund Advisor – Rhode Island

Rating: Negative

Program Manager: AllianceBernstein

State’s Total AUM: $7.7. billion/Rank: 6th

11. CollegeBound Fund Direct – Rhode Island

Rating: Negative

Program Manager: AllianceBernstein

State’s Total AUM: $7.7. billion/Rank: 6th

12. Minnesota Savings Plan Direct

Rating: Negative

Program Manager: TIAA Tuition Financing

State’s Total AUM: $1.1 billion/Rank: 33rd

13. Schwab 529 College Savings Plan Direct – Kansas

Rating: Negative

Program Manager: American Century

State’s Total AUM: $4.2 billion/Rank: 13th

---

Related ThinkAdvisor stories: